CN105388297A - Application of mycobacterium tuberculosis protein Rv1984c in preparing products for diagnosing latent phthisis infection - Google Patents

Abstract

The invention provides the application of mycobacterium tuberculosis protein Rv2693c and/or Rv1984c in developing and/or designing products for identification, diagnosis, auxiliary diagnosis, screening and/or auxiliary screening of latent phthisis infection. The invention also provides a protein chip prepared with the two kinds of mycobacterium tuberculosis protein. By the adoption of the protein chip, the levels of IgM antibodies corresponding to the two kinds of protein in serum of latent phthisis infection patients and normal people are detected, the detection results of the corresponding antibodies of the two kinds of protein are analyzed in a combined mode, and whether an inspected person suffers from latent phthisis infection is judged. Detection results show that the specificity of the best operating point of auxiliary diagnosis of latent phthisis infection of the protein chip is 80.3%, sensitivity is 75.6%, and both indexes are higher than those of latent phthisis infection diagnosis in the prior art.

Description

The purposes of Mycobacterium tuberculosis albumen Rv1984c in the product of preparation diagnosis latent tuberculosis infection

The divisional application that the application is application number is 201310607359.0, the applying date is 2013.11.25, invention and created name is " purposes of Mycobacterium tuberculosis albumen in the product of preparation diagnosis latent tuberculosis infection "

Technical field

The invention belongs to biomedicine field, be specifically related to the purposes of Mycobacterium tuberculosis albumen in the product preparing diagnosis and/or auxiliary diagnosis disease.

Background technology

Since multiple century, tuberculosis continues to become a public health problem that can not be ignored in the whole world.The population in the current whole world existing 1/3rd carries Much's bacillus, and only within 2010 1 year, just increase cases of tuberculosis 8,800,000 newly, dead 1,450,000, on average namely had a people to die from pulmonary tuberculosis less than 22 seconds, tuberculosis is in first of Death of Infectious Diseases number.And China is one of 22 tuberculosis high burden countries in the whole world, tuberculosis patient number is in global second, infected number is more than 500,000,000, only within 2010 1 year, just there are new cases 90 ~ 1,200,000, occupying about 12% of the total new cases in the whole world, as adopted an effective measure not in time, 3,000 ten thousand people's morbidities may be had within Future Ten year, serious public health problem and social concern will be caused, so must realize as early as possible phthisical effective control from national strategy aspect.

Scientific evidence shows, after tuberculosis infection human body, in most of the cases, can be subject to immune control in human body, thus be in a latent infection state, likely be converted into active tuberculosis at any time.Considering global tuberculosis infection population, is even all a very huge numeral in China, and in conjunction with transmissibility lungy and social harm, in healthy population, the examination tuberculosis patient that hides just seems particularly important.Existing research confirms that latent tuberculosis infects (latenttuberc μ losisinfection, LTBI) prophylactic treatment can reduce the risk (BucherHC that HIV/TB double infection crowd progress is activity TB, GriffithLE, GuyattGH, etal:Isoniazidprophylaxisfortuberc μ losisinHIVinfection:ameta-analysisofrandomizedcontrolled trails [J] .AIDS, 1999,13:501-508).But the result of current domestic diagnosis latent infection Main Basis tuberculin skin test (PPD skin test), it is generally acknowledged PPD strong positive or transfers the positive person that is latent tuberculosis infection to from feminine gender in a short time.But because PPD skin test cannot distinguish the immune response and the responsing reaction that produces of latent infection that the BCG inoculation extensively promoted in China produces.And based on the serodiagnosis of antigen-antibody reaction, due to its simplicity, rapidity, be that important latent tuberculosis infects clinical complementary diagnostic means.Therefore, from a long-term perspective, should be devoted to find Sensitivity and Specificity tuberculosis mark all preferably.

Desirable Diagnosis of Tuberculosis mark should meet following condition: (1) susceptibility is high; (2) specificity is high; (3) be present in body fluid, particularly in blood, be easy to detect.But at present Mycobacterium tuberculosis serodiagnosis for antigen as antigen 5,38KD antigen, 30/31KD antigen and antigen 60 etc., all there is positive rate low, with problems such as the cross-immunities of other mycobacterium, although have certain value in the generaI investigation of curative effect monitoring, prompting recurrence, judging prognosis and people at highest risk, what still can not be used for that latent tuberculosis infects at present makes a definite diagnosis.In order to realize the high sensitivity infected latent tuberculosis, the diagnosis of high specific, be badly in need of searching out more responsive, more special latent tuberculosis infection biological mark on a molecular scale.

Summary of the invention

An object of the present invention is to provide the product that detects anti-Rv2693c antibody and/or anti-Rv1984c antibody horizontal in serum and there is in preparation application in the product of discriminatings, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infection purposes.

In described application, described Rv2693c is following albumen a) or b):

The protein of the amino acid sequence composition shown in the SEQIDNo.1 a) in sequence table;

B) by the amino acid residue sequence of the SEQIDNo.1 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.1 have identical function by a) derivative protein;

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein;

And/or, described have discriminating, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis to infect in the product of purposes, comprise the instructions being described below content: compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and in anti-Rv2693c antibody horizontal and anti-Rv1984c antibody horizontal, at least one significantly raises.

Described antibody is IgM.

Another object of the present invention be to provide a kind of for differentiating, diagnosing, the mark composition that infects of auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis, be made up of the antibody of anti-Rv2693c and the antibody of anti-Rv1984c;

In described mark composition, antibody described in each is behaved the antibody in vitro serum;

Described antibody is IgM.

Described Rv2693c is following albumen a) or b):

The protein of the amino acid sequence composition shown in the SEQIDNo.1 a) in sequence table;

B) by the amino acid residue sequence of the SEQIDNo.1 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.1 have identical function by a) derivative protein;

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein.

Another object of the present invention is to provide the antibody of the anti-Rv2693c in serum and/or the antibody of anti-Rv1984c and has application in the product of discriminatings, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infection purposes as mark in exploitation, design and/or preparation; Described Rv2693c is following albumen a) or b):

The protein of the amino acid sequence composition shown in the SEQIDNo.1 a) in sequence table;

B) by the amino acid residue sequence of the SEQIDNo.1 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.1 have identical function by a) derivative protein;

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein;

Described have discriminating, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis to infect in the product of purposes, comprise the instructions being described below content: compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and in anti-Rv2693c antibody horizontal and anti-Rv1984c antibody horizontal, at least one significantly raises.

Described antibody is IgM.

In described arbitrary application, described discriminating, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infect and specifically refer to whether discriminating, diagnosis and/or auxiliary diagnosis people to be measured suffer from latent tuberculosis and infect; Or in examination and/or auxiliary examination crowd to be measured, suffer from the situation that latent tuberculosis infects.

Also object of the present invention be to provide a kind of for differentiating, diagnosing, the kit that infects of auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis, comprise detection chip, described detection chip is connected with at least a kind of albumen in Rv2693c and Rv1984c albumen, often kind of albumen sets up separately a check point; Preferably, described detection chip is connected with Rv2693c and Rv1984c albumen;

Described Rv2693c is following albumen a) or b):

The protein of the amino acid sequence composition shown in the SEQIDNo.1 a) in sequence table;

B) by the amino acid residue sequence of the SEQIDNo.1 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.1 have identical function by a) derivative protein;

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein.

In described kit, described detection chip is made on carrier slide by the solution point sample respectively containing Rv2693c and/or Rv1984c albumen.

In described kit, the described solution respectively containing Rv2693c and/or Rv1984c albumen, by solute and solvent composition, described solute and the concentration in described solution thereof are:

In described solution, also comprise: the NaN that the glycerine that percent by volume is 25%, percent by volume are BSA and 0.1g/L of Tween20,0.05mg/ml of 0.02% ₃.

Described point sample specifically adopts biochip point sample instrument point sample; The point sample volume of described point sample is 0.3-1nl; Preferred 0.5-1nl; Most preferably 1nl

What described carrier slide specifically adopted is three-dimensional H carrier slide.

After described point sample terminates, also need the plastics fence sticking 12 holes, and after remaining on and spending the night in 30%RH-40%RH humidity 4 DEG C of environment, slide is positioned in plastic casing and seals-80 DEG C of Cord blood; Preferably, humidity is 35%RH.

Described kit also comprises IgM positive control and/or Cy5 marks anti-human second antibody;

Described kit also comprises instructions, and described instructions is described below content:

Compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and in anti-Rv2693c antibody horizontal and anti-Rv1984c antibody horizontal, at least one antibody significantly raises.

In described anti-Rv2693c antibody horizontal and anti-Rv1984c antibody horizontal, at least one antibody significantly raises and judges as follows: in the testing result of testing sample, in anti-Rv2693c antibody and/or anti-Rv1984c antibody, has a kind of antibodies positive at least, then judge that this testing sample is that latent tuberculosis infects the positive, otherwise be that latent tuberculosis infects feminine gender;

Be between following value if the criterion of described antibodies positive is the snr value of each antibody, then think this antibodies positive: the snr value of the antibody of Rv2693c is between 2.30 and 2.35, comprises 2.30 and 2.35; The snr value of the antibody of Rv1984c is between 2.24 and 2.38, comprises 2.24 and 2.38.

Described anti-Rv2693c antibody and/or anti-Rv1984c antibody specific are IgM.

The computing formula of described snr value is:

$SNR=\frac{S-B}{\mathrm{\σ}}$

In formula, S and B represents the background value in signal value that in described detection chip, scanner directly shows and non-sample spot region respectively, and σ is then the standard deviation representing this original signal; The experiment number that described σ is corresponding is 3 times; Described S and B value scanner obtains at 635nm Channel scan; Described scanner is GenePix.

In described kit, described kit also comprises the reagent coordinating detection chip to use together, and described reagent comprises following 1)-4):

1) pH7.4PBS solution, it consists of:

2) the PBST solution of pH7.4, it consists of:

3) containing the pH7.4PBS solution of BSA:

4) fluorescently-labeled anti-human second antibody.

Described anti-human second antibody is specially anti-human IgM second antibody.

Last object of the present invention be to provide above-mentioned arbitrary described kit preparation have discriminatings, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infection purposes product in application.

Accompanying drawing explanation

Fig. 1 is the silver dye quantitative result figure of 2 prepared antigen protein Rv2693c, Rv1984c.

Fig. 2 is the Western-Blotting qualification result figure of 2 prepared antigen protein Rv2693c, Rv1984c.

Fig. 3 is specificity and the susceptibility statistics figure of the method that application protein-chip auxiliary diagnosis latent tuberculosis infects.

Embodiment

The experimental technique used in following embodiment if no special instructions, is conventional method.

Material used in following embodiment, reagent etc., if no special instructions, all can obtain from commercial channels.

The preparation of embodiment 1, protein-chip

(1) preparation of Mycobacterium tuberculosis antigen protein Rv2693c, Rv1984c

1, express

Utilize galactose to induce overexpression by the saccharomyces cerevisiae of genetic engineering modified mistake, detailed process is:

First from mycobacterium Much's bacillus (MycobacteriumM.tuberculosis) H37Rv bacterial strain (Beijing Strain), from the beginning cloned by PCR and obtain albumen Rv2693c, the gene code fragment of Rv1984c, by the BP enzyme of Invitrogen company, fragment is connected on pDONR221 carrier (purchased from Invitrogen), be transformed in bacillus coli DH 5-Alpha and increase, extract carrier again by LR enzyme (Invitrogen) change to through transformation the pEGH-A carrier can expressing GST label (this carrier is at " JianZhu, HengZhu, etal:J.Virol.May2009vol.83no.105219-5231 " in be disclosed, the public can obtain from Ti Bikang bio tech ltd, Guangdong), again be transformed in bacillus coli DH 5-Alpha and increase, (this bacterial strain is at document " HengZhu to Pep4 Wine brewing yeast strain to extract Plastid transformation, MichaelSnyder, etal:NatureGenetics26, 283 – 289 (2000) doi:10.1038/81576 " in be disclosed, the public can obtain from Ti Bikang bio tech ltd, Guangdong).Cultivate in inducing culture, when its OD600 is 0.6-0.8, add the galactose that final concentration is 2g/L, induction 6h, 4000rpm collected by centrifugation bacterium ,-80 DEG C of preservations.

The PCR primer sequence used during from the beginning PCR clones is as follows:

The primer pair of the gene code fragment of amplification Rv2693c albumen:

Upstream primer: GGGGACAAGTTTGTACAAAAAAGCAGGCTTAAACGCTAACCGCACTAGCGCCCA

Downstream primer: GGGGACCACTTTGTACAAGAAAGCTGGGTACTACTCGCGGCCGGCGTCG

The primer pair of the gene code fragment of amplification Rv1984c albumen:

Upstream primer: GGGGACAAGTTTGTACAAAAAAGCAGGCTTAACTCCACGCAGCCTTGTT

Downstream primer: GGGGACCACTTTGTACAAGAAAGCTGGGTATCATCCGGCGTGATCGAG

The component contained in every 1L inducing culture (solvent is water) is as shown in table 1:

Table 1

2, purifying

1), lysate is prepared:

50 μ l mercaptoethanols are added, 125 μ lPMSF and two panels Roche protein inhibitor in 50ml lysate;

2), take out in-80 DEG C of refrigerators above-mentioned steps 1 collect bacterium (cultivating the thalline collected from 120ml inducing culture), add 400 μ l zirconium oxide beads and 400 μ l lysates, shake 30s in 4 DEG C of environment, rearmounted 2min on ice, repeat four times;

3), take out after the centrifugal 2min of 11,000rpm, get supernatant in a new 15ml centrifuge tube;

4), repeat 2 and 3 step four times, supernatant is collected in same centrifuge tube;

5), lysate is added to 1/10 of 12ml and original inducing culture volume, simultaneously with not having the lysate of inhibiting that glutathione beads is cleaned 3 times.The beads of 300 μ l is added in 12ml lysate;

6), add the lysate after beads and hatch 2h in 4 DEG C;

7), get supernatant after 11,000rpm centrifugal 2min and be stored in 4 DEG C.Beads cleaning fluid Ι and cleaning fluid II respectively washes 3 times;

8), add after 300 μ l eluents hatch 15min, centrifuging and taking supernatant is collected in a new centrifuge tube, repeats once.

Namely the eluent obtained is dissolved with this albumen.

The composition of damping fluid (solvent is water) used in above-mentioned purge process is in Table 2-table 5.

Table 2 lysate (1L)

Table 3 cleaning fluid I (1L)

Table 4 cleaning fluid II (1L)

Table 5 eluent (1L)

3, identify

In following experimentation, described solvent or the percentage of liquid are percent by volume.

1), material preparation

Configure the SDS-PAGE glue of two piece 12%, 1.0mm, 15 holes.One piece of silver dye, one piece of WesternBlotting.Get each 20 μ l of the good albumen of above-mentioned purifying, add 4 μ l6XLoadingbuffer, the BSA sample simultaneously preparing specification concentration gradient contaminates quantitative control as silver, boils sample 5min.

2), glue is run

Every hole adds the above-mentioned sample prepared of 12 μ l, BSA gradient sample successively, and 2.5 μMs of arker (Takara) record order.80V30min，140V1h。

3) silver dye operation steps:

Fixing: 30min or longer time 40% ethanol 10% glacial acetic acid add water 250ml

Sensitization: 30min75ml ethanol 30% ethanol 17g sodium acetate 28.2g sodium acetate trihydrate 0.5g sodium thiosulfate (dodium thiosulfate) adds water final volume 250ml

Washing: 3x10min

Silver dye: 20min0.625gAgNO3100 μ l37% formaldehyde (adding before use) adds water final volume 250ml

Washing: 2x1min

Colour developing: the time depends on the circumstances 6.25gNa ₂cO ₃50 μ l37% formaldehyde (adding before use) add water final volume 250ml

Stop: 10min1g glycocoll adds water final volume 250ml

Preserve: 1% glacial acetic acid, 4 DEG C

4) Western-Blotting step:

Transferring film: 15V40min (half-dried turn, Bio-Rad).Transferring film damping fluid: glycocoll 2.9g; Tris5.8g; SDS0.37g; Methyl alcohol 200ml; Add ddH ₂o is settled to 1000ml

Close: 5% skim milk (Bio-Rad) 1h.

First antibody is hatched: Anti-GST mouse-anti (NovaGen) final concentration 1 μ g/ml1h

Second antibody is hatched: sheep mouse-anti fluorescence 800 passage (Odyssey) final concentration 1 μ g/ml1h

Odyssey scanner scanning, preserves picture.

Carry out silver dye quantitatively and the result difference of Western-Blotting qualification as depicted in figs. 1 and 2.Fig. 1 result shows that the amount of prepared Rv2693c and Rv1984c albumen is 50 μ g/ml; Fig. 2 result proves, prepared Rv2693c and Rv1984c albumen is correct.

Through order-checking, prepared Rv2693c, Rv1984c albumen has the amino acid sequence shown in SEQ ID No .1-2 respectively successively.

(2) preparation of the protein-chip of pre-some antigen

In the eluate solution of the Rv2693c antigen protein of the 50 μ g/ml containing above-mentioned preparation, add the NaN of BSA and 0.1g/L of Tween20,0.05mg/ml of glycerine that final concentration is 25% (percent by volume), 0.02% (percent by volume) ₃.Adopt biochip point sample instrument by above-mentioned mixed liquor point on carrier slide (carrier slide is commercial three-dimensional H carrier slide, purchased from CapitalBio Corporation), often some point sample is about 1nL, 2 parallel points.Adopt biochip point sample instrument (purchased from CapitalBio Corporation) some system.

Above-mentioned Rv2693c antigen protein replaced with Rv1984c antigen protein (being 50 μ g/ml), mark anti-human second antibody (20 μ g/ml) as IgM (1mg/ml) standard items of positive control or Cy5, in mixed liquor other component and final concentration constant, prepare and mark the mixed liquor of anti-human second antibody containing Rv1984c antigen protein, IgM standard items or Cy5 respectively.

With above-mentioned identical spotting methods, will mark the mixed liquor point of anti-human second antibody on above-mentioned identical carrier slide respectively, and form microarray containing Rv1984c albumen, IgM standard items or Cy5, every slide can be put 12 and repeat parallel seal interval.Stick the plastics fence in 12 holes after point sample terminates, and to remain in 35%RH humidity 4 DEG C of environment after 16h, slide is positioned in plastic casing and seals-80 DEG C of Cord blood.

Embodiment 2, application protein-chip auxiliary diagnosis latent tuberculosis infect

(1) preparation of test serum sample

Whole blood sample after room temperature places 2 hours or 4 DEG C are spent the night in 1000g centrifugal about 20 minutes, getting supernatant can detect immediately; Or carry out packing, and sample is put in-20 DEG C or-80 DEG C of preservations, but should multigelation be avoided.4 DEG C thaw after sample should be again centrifugal, then detect.

(2) involved in diagnostic procedure various damping fluid and the preparation of reagent

(1) sample diluting liquid (see table 6): pH7.4PBS solution

Table 6

(2) the PBST solution of cleansing solution (see table 7): pH7.4

Table 7

(3) chip confining liquid (see table 8): containing the pH7.4PBS solution of BSA

Table 8

(4) Cy5 marks the concentrate of anti-human second antibody: use commercially available anti-human IgM-Cy5 fluorescence labeling two to resist, being diluted to concentration is 1mg/ml, is sub-packed in lucifuge tubule.

(3) method that protein-chip auxiliary diagnosis latent tuberculosis infects is applied

The protein-chip using embodiment 1 to prepare can to detect in tested person's blood sample the level of 2 proteantigens Rv2693c, Rv1984c IgM antibody accordingly separately, the testing result of the corresponding antibodies of these 2 protein of Conjoint Analysis, can judge whether tested person is that latent tuberculosis infects.

1, concrete operation step

1) embodiment 1 is made the chip of sealing from-80 DEG C of taking-ups, room temperature rewarming 10 minutes.

2) close: chip is put into sink, adds about 50ml chip confining liquid (see table 8), shaking table 50rpm, room temperature 1h.

3) get rid of liquid unnecessary on chip fast, be placed in wet box.

4) dilution of testing sample and application of sample: by test serum sample by volume the 1:100 sample diluting liquid (see table 6) of above-mentioned preparation dilute, get 30 μ L dilute after the solution containing test serum join in closed fence-enclosing space.Reaction 1h, room temperature.Detected sample is prepared in 15 minutes before use.

5) chip is taken out from wet box, be placed in sink, add the cleansing solution of the above-mentioned preparation of about 50ml, shaking table 50rpm, room temperature 5min, repeat 3 times.

6) get rid of liquid unnecessary on chip fast, be placed in wet box.

7) each enclosure space adds the Cy5 fluorescence anti-human two that 30 μ L have been diluted to final concentration 1 μ g/ml and resists on chip, lucifuge reaction 1h.

8) chip is taken out from wet box, be placed in sink, add the cleansing solution of the above-mentioned preparation of about 50ml, shaking table 50rpm, room temperature 5min, repeat 3 times.Use the ultrapure washing of about 50ml more once, 5min.

9) centrifugal drying, reads data with Genepix scanner under 635nm passage.

2, testing sample is respectively to the judgement of 2 kinds of antigen protein resistances

Be weighed by the signal to noise ratio (S/N ratio) (SNR) of point of sample with Genepix scanner in the result that 635nm Channel scan obtains, signal to noise ratio (S/N ratio) (SNR) computing formula of point of sample is:

$SNR=\frac{S-B}{\mathrm{\σ}}$

In formula, S and B represents signal value (being the numerical value that scanner directly shows) original in chip and background value (signal value in non-sample spot region) respectively, and σ is then the standard deviation (experiment number that σ is corresponding is 3 times) representing this original signal.

The snr value of point of sample on protein-chip and the following signal to noise ratio (S/N ratio) interval (described signal to noise ratio (S/N ratio) interval comprises the endpoints thereof in given signal to noise ratio (S/N ratio) interval) showing 9-table 10 are contrasted, to carry out the positive of testing sample to corresponding antigens resistance, the judgement of negative findings:

Anti-Rv2693c (see table 9):

Table 9

Anti-Rv1984c (see table 10):

Table 10

3, the judgement of testing sample assay

Criterion:

Compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and in anti-Rv2693c antibody horizontal and anti-Rv1984c antibody horizontal, at least one antibody significantly raises, and is embodied in:

If in the testing result of testing sample, (judge that whether antibody be positive standard: when 2 parallel point of samples of same antigen are all judged to be the positive on protein-chip prepared by embodiment 1, this antibody be the positive to anti-Rv2693c antibody horizontal with having a kind of antibodies positive in anti-Rv1984c antibody at least.), then judge that this testing sample is that latent tuberculosis infects the positive, otherwise be that latent tuberculosis infects feminine gender.

(4) specificity and the susceptibility of the method that protein-chip auxiliary diagnosis latent tuberculosis infects, is applied

(clinical diagnosis is the patient 100 parts that latent tuberculosis infects, Healthy People 100 parts to adopt 200 parts of latent tuberculosis to infect the serum of associated patient; Serum sample is provided by Tubercufosis control center, Guangdong Province, the informed consent obtained all through patient and examinee of serum sample.) specificity and sensitivity Detection have been carried out to the protein-chip of embodiment 1, judge whether person to be measured infects as latent tuberculosis with above-mentioned criterion positive.

Testing result as shown in Figure 3.Horizontal ordinate false positive rate representative (1-specificity) in Fig. 1, ordinate True Positive Rate represents susceptibility.The specificity calculating the best operating point of the protein-chip auxiliary diagnosis latent tuberculosis infection of embodiment 1 according to positive likelihood ratio and susceptibility/(1-specificity) is 80.3%, susceptibility is 75.6%, is all much higher than the index of latent tuberculosis Infect And Diagnose in prior art.

In 100 parts of latent tuberculosis infected patients, 80 parts are detected the positive; In 100 parts of Healthy Peoples, 24 parts are had to be detected the positive.

Claims (9)

1. in detection serum anti-Rv1984c antibody horizontal product preparation have discriminatings, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infection purposes product in application.

2. application according to claim 1, is characterized in that:

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein;

Described have discriminating, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis to infect in the product of purposes, comprise the instructions being described below content: compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and anti-Rv1984c antibody horizontal significantly raises.

3. the antibody of the anti-Rv1984c in serum to have the application in the product of discriminatings, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infection purposes in exploitation, design and/or preparation as mark;

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein;

Described have discriminating, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis to infect in the product of purposes, comprise the instructions being described below content: compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and anti-Rv1984c antibody horizontal significantly raises.

4. for differentiating, diagnosing, the kit that infects of auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis, comprise detection chip, described detection chip is connected with Rv1984c albumen, described Rv1984c albumen is a check point;

Described Rv1984c is following albumen c) or d):

The protein of the amino acid sequence composition shown in the SEQIDNo.2 c) in sequence table;

D) by the amino acid residue sequence of the SEQIDNo.2 in sequence table through the replacement of one or several amino acid residue and/or disappearance and/or interpolation and with albumen shown in SEQIDNo.2 have identical function by c) derivative protein.

5. kit according to claim 6, is characterized in that: described detection chip is made on carrier slide by the solution point sample containing Rv1984c albumen.

6. the kit according to claim 4 or 5, is characterized in that: described kit also comprises instructions, and described instructions is described below content:

Compared with normally not suffering from the people of any disease, latent tuberculosis infects in people, and anti-Rv1984c antibody horizontal significantly raises.

7. kit according to claim 6, is characterized in that:

Described anti-Rv1984c antibody horizontal significantly raises and judges as follows: in the testing result of testing sample, anti-Rv1984c antibodies positive, then judge that this testing sample is that latent tuberculosis infects the positive, otherwise be that latent tuberculosis infects feminine gender;

Be between following value if the criterion of described antibodies positive is the snr value of the antibody of Rv1984c, then think this antibodies positive: the snr value of the antibody of Rv1984c is between 2.24 and 2.38, comprises 2.24 and 2.38.

8. the kit according to claim 4 or 5, is characterized in that: described kit also comprises the reagent coordinating detection chip to use together, and described reagent comprises following 1)-4):

1) pH7.4PBS solution, it consists of:

2) the PBST solution of pH7.4, it consists of:

3) containing the pH7.4PBS solution of BSA:

4) fluorescently-labeled anti-human second antibody.

9. the arbitrary described kit of claim 4-8 preparation have discriminatings, diagnosis, auxiliary diagnosis, examination and/or auxiliary examination latent tuberculosis infection purposes product in application.